Hsin Yang Liu

Corporate Officer/Principal en TSH BIOPHARM CORPORATION LIMITED .

Health Technology

Consumer Services

Perfil

Hsin Yang Liu is currently the Vice General Manager-General Administration at TSH Biopharm Corp., Ltd.
Previously, she held the position of VP-Administrative, Director-Accounting & Finance at Body Organ Biomedical Corp.
in 2012.
She also served as a Member-Supervisory Board at Reber Genetics Co., Ltd.
Dr. Liu completed her undergraduate and graduate degrees at National Taiwan University and obtained a doctorate degree from Nankai University.

Cargos activos de Hsin Yang Liu

Empresas	Cargo	Inicio
TSH BIOPHARM CORPORATION LIMITED	Corporate Officer/Principal	-

Todos los cargos activos de Hsin Yang Liu

Antiguos cargos conocidos de Hsin Yang Liu.

Empresas	Cargo	Fin
REBER GENETICS CO LTD	Director/Board Member	-
BODY ORGAN BIOMEDICAL CORP	Director of Finance/CFO	-

Ver el detalle de la experiencia de Hsin Yang Liu.

Formación de Hsin Yang Liu.

National Taiwan University	Graduate Degree
Nankai University	Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Hsin Yang Liu.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
TSH BIOPHARM CORPORATION LIMITED	Health Technology

Empresas privadas	2
Body Organ Biomedical Corp. Body Organ Biomedical Corp. BiotechnologyHealth Technology Body Organ Biomedical Corp. engages in the research, development, manufacture and sales of biomedical devices. It also provides regenerative solutions to restore tissue damage in orthopedics, dentistry, ophthalmology, reconstructive and general surgery. The company was founded on May 4, 2007 and is headquartered in Taipei, Taiwan.	Health Technology
Reber Genetics Co., Ltd. Reber Genetics Co., Ltd. Pharmaceuticals: MajorHealth Technology Reber Genetics Co., Ltd. engages in the research, development, production, and sale of animal vaccines. Its products include PRRS and PCV2 subunit vaccines. The company was founded on April 18, 2008 and is headquartered in Taipei, Taiwan.	Health Technology